tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ping An Biomedical Faces Nasdaq Listing Compliance Challenge

Story Highlights
  • Ping An Biomedical received a Nasdaq deficiency letter for not meeting the $1 minimum bid price requirement.
  • The company has until May 25, 2026, to regain compliance or face potential delisting.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Ping An Biomedical Faces Nasdaq Listing Compliance Challenge

Claim 50% Off TipRanks Premium

Ping An Biomedical ( (PASW) ) has shared an announcement.

On November 24, 2025, Ping An Biomedical Co., Ltd. received a Nasdaq Minimum Bid Price Deficiency Letter, indicating that the company no longer meets the Nasdaq listing requirement of maintaining a minimum bid price of $1 per share. The company has been given until May 25, 2026, to regain compliance, with a possible extension of an additional 180 days if certain conditions are met. Ping An Biomedical is exploring options to address this issue and aims to regain compliance, although there is no assurance of success.

More about Ping An Biomedical

Ping An Biomedical Co., Ltd. is a one-stop SCM service provider in the apparel industry and also focuses on delivering innovative solutions in healthcare and biomedical technology.

Average Trading Volume: 1,091,714

Technical Sentiment Signal: Strong Sell

Current Market Cap: $9.71M

For an in-depth examination of PASW stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1